SOLVENT FREE AMORPHOUS RAPAMYCIN
    1.
    发明申请
    SOLVENT FREE AMORPHOUS RAPAMYCIN 审中-公开
    无溶剂的无定形RAPAMYCIN

    公开(公告)号:US20080227982A1

    公开(公告)日:2008-09-18

    申请号:US12127467

    申请日:2008-05-27

    IPC分类号: C07D491/16

    CPC分类号: C07D498/18

    摘要: An improved process for coating implantable medical devices utilizes a number of techniques for improving the stability of therapeutic agents contained within the coating. The stability of the therapeutic agents may be improved by creating substantially solvent-free, amorphous forms of the therapeutic agents.

    摘要翻译: 用于涂覆可植入医疗装置的改进方法利用许多技术来改善包含在涂层内的治疗剂的稳定性。 通过产生基本无溶剂的无定形形式的治疗剂可以改善治疗剂的稳定性。

    Solvent free amorphous rapamycin
    2.
    发明授权
    Solvent free amorphous rapamycin 有权
    无溶剂无定形雷帕霉素

    公开(公告)号:US07393952B2

    公开(公告)日:2008-07-01

    申请号:US11210393

    申请日:2005-08-24

    IPC分类号: C07D498/18

    CPC分类号: C07D498/18

    摘要: An improved process for coating implantable medical devices utilizes a number of techniques for improving the stability of therapeutic agents contained within the coating. The stability of the therapeutic agents may be improved by creating substantially solvent-free, amorphous forms of the therapeutic agents.

    摘要翻译: 用于涂覆可植入医疗装置的改进方法利用许多技术来改善包含在涂层内的治疗剂的稳定性。 通过产生基本无溶剂的无定形形式的治疗剂可以改善治疗剂的稳定性。

    Process for preparing 1, 5-diaryl-3-substituted pyrazoles
    4.
    发明授权
    Process for preparing 1, 5-diaryl-3-substituted pyrazoles 有权
    制备1,5-二芳基-3-取代的吡唑的方法

    公开(公告)号:US06613914B2

    公开(公告)日:2003-09-02

    申请号:US10086583

    申请日:2002-03-01

    IPC分类号: C07D23112

    摘要: A process for making a compound of formula I wherein the substituents are as described in the specification comprising reacting a ketone of formula II with succinic anhydride and an alkoxide base to form a compound of formula III which is reacted with a compound of formula IV to form a compound of V and reacting with an alcohol to form the corresponding ester of formula VI and reacting the ester with N-methylhydroxylamine.

    摘要翻译: 制备式I化合物的方法,其中取代基如说明书中所述包括使式II的酮与琥珀酸酐和醇盐碱反应形成式III化合物,其与式IV化合物反应形成 钒的化合物与醇反应以形成相应的式VI的酯,并使酯与N-甲基羟胺反应。

    Certain hexahydro-6-arylpyrrolo[2,1-A]isoquinolines
    10.
    发明授权
    Certain hexahydro-6-arylpyrrolo[2,1-A]isoquinolines 失效
    某些六氢-6-芳基吡咯并[2,1-A]异喹啉

    公开(公告)号:US4908450A

    公开(公告)日:1990-03-13

    申请号:US304304

    申请日:1989-01-31

    IPC分类号: C07D471/04

    CPC分类号: C07D471/04

    摘要: A diastereoselective process for known antidepressive compounds (I) via reduction of the corresponding alcohol (VII): ##STR1## whereby the product mixture of diastereomers is surprisingly and unexpectedly rich in the content of the trans configuration (II) over the cis configuration (III) as defined in the following formulae: ##STR2## The preferred reaction conditions include use of a borane complex as the reducing agent and an acidic solvent such as trifuloroacetic acid.

    摘要翻译: 通过还原相应的醇(VII),已知的抗抑郁化合物(I)的非对映选择性方法:其中非对映异构体的产物混合物出人意料地且意外地富含 (III)优选的反应条件包括使用硼烷配合物作为还原剂和酸性溶剂如 作为三氟乙酸。